Skip to content

Determination of the minimum effective concentration (MEC90) of oxycodone for Preventing perioperative chills in women with intrvertebral block cesarean sectionby biased coin design up and down Order Method (BCD-UDM)

Determination of the minimum effective concentration (MEC90) of oxycodone for Preventing perioperative chills in women with intrvertebral block cesarean section by biased coin design up and down Order Method (BCD-UDM)

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074863
Enrollment
Unknown
Registered
2023-08-18
Start date
2023-08-20
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chill

Interventions

Chilling group:The first participant received oxycodone 80 µg/kg intravenously after the infant's section. When the previous subject had chills, the concentration of the next subject increased by 5 µg
Non-chill group:When chills were not observed in the previous patient, the next patient was randomized to receive the same dose of oxycodone (probability 0.89) or oxycodone at a concentration 5 µg/kg

Sponsors

Hangzhou First People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. ASAI-II level; 2. Age 18-40 years old; 3. 150cm= height = 170cm, weight = 100kg; 4. Gestational age= 37 weeks; 5. Patients undergo routine pregnancy examination; 6. There are no abnormalities in blood routine and coagulation function; 7. Heart, liver, lung, kidney and other functions are correct; 8. Elective caesarean section under lumbar hard combined anesthesia; 9. The mother signs the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Allergic to the drugs used in the Institute; 2. Spinal deformity; 3. Twin and/or multiple pregnancies; 4. Coagulation dysfunction; 5. Infection at the puncture site; 6. Maternal refusal to participate in this study;

Design outcomes

Primary

MeasureTime frame
MEC90;

Secondary

MeasureTime frame
Incidence of chills;Chill grading;When and how long chills occur;Ramsay score ;Heart rate and blood pressure change every 5 minutes after administration;Incidence of adverse events (nausea, vomiting, respiratory depression).;Postoperative 2h and 6h VAS pain scores;

Countries

China

Contacts

Public ContactJianliang Sun

Hangzhou First People's Hospital

sjl6805@zju.edu.cn+86 139 5806 9878

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026